Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,683 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

Intrathecal Double Checkpoint Inhibition

NCT05598853

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • University Hospital Zurich Zurich, Canton of Zurich, Switzerland
  • University Hospital Basel Basel, Switzerland
  • University Hospital Geneva Geneva, Switzerland
View Trial Details
Active, Not Recruiting

Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET

NCT03993873

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Advanced Solid Tumor, +27 more
Locations
  • Local Institution - 2102 La Jolla, California, United States
  • Local Institution - 2108 Orange, California, United States
  • Local Institution - 2105 Denver, Colorado, United States
  • Local Institution - 2111 Chicago, Illinois, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer

NCT04986670

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • The James Cancer Hospital Columbus, Ohio, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

SI-B001 Combined With Osimertinib Mesylate Tablets in the Treatment of Recurrent Metastatic Non-small Cell Lung Cancer.

NCT05020769

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guilin Medical University Guilin, Guangxi, China
  • Sun Yat-sen University Cancer Center (SYSUCC) Guangdong, Guangzhou, China
View Trial Details
Active, Not Recruiting

A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

NCT04606472

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +43 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
View Trial Details
Active, Not Recruiting

SI-B001 Combined With Chemotherapy in the Treatment of EGFR/ALK WT Recurrent or Metastatic NSCLC.

NCT05020457

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • Sun Yat-sen University Cancer Center (SYSUCC) Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • The Second Affiliated Hospital of Guilin Medical University Guilin, Guangxi, China
View Trial Details
Active, Not Recruiting

A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation

NCT05485974

Conditions
Bronchial Neoplasms, Cancer, Cancer of Pancreas, +28 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. (cCare) Encinitas, California, United States
  • The Oncology Institute of Hope and Innovation Glendale, California, United States
  • The Oncology Institute of Hope and Innovation Long Beach, California, United States
  • The Oncology Institute of Hope and Innovation Pasadena, California, United States
View all 14 locations
View Trial Details

Related conditions